These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 25098485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The case of a 43-year old Turkish male patient with Nasu-Hakola disease.
    Maner F, Ipekçioğlu D, Karamustafalıoğlu N, Karagöz Sakallı N, Cetinkaya O, Ilnem MC, Konuk N.
    Asian J Psychiatr; 2013 Dec; 6(6):631-2. PubMed ID: 24309893
    [No Abstract] [Full Text] [Related]

  • 3. Early-onset dementia, leukoencephalopathy and brain calcifications: a clinical, imaging and pathological comparison of ALSP and PLOSL/Nasu Hakola disease.
    Coomans C, Sieben A, Lammens M, Ceuterick-de Groote C, Vandenbroecke C, Goethals I, Van Melkebeke D, Hemelsoet D.
    Acta Neurol Belg; 2018 Dec; 118(4):607-615. PubMed ID: 30242731
    [Abstract] [Full Text] [Related]

  • 4. Nasu-Hakola disease revealed on X-ray.
    Ohtani R, Shibuya K, Satoh J, Kuwabara S.
    Intern Med; 2014 Dec; 53(20):2407. PubMed ID: 25318814
    [No Abstract] [Full Text] [Related]

  • 5. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy): First report from India.
    Chepuru R, Shaik AJ, Tandra SR, Gaddamanugu P, Alladi S, Kaul S.
    Neurol India; 2018 Dec; 66(2):538-541. PubMed ID: 29547188
    [No Abstract] [Full Text] [Related]

  • 6. Neuropathological Alzheimer's Disease Lesions in Nasu-Hakola Disease with TREM2 Mutation: Atypical Distribution of Neurofibrillary Changes.
    Maderna E, Visonà S, Bolcato V, Redaelli V, Caroppo P, Montalbetti L, Giaccone G, Osculati A.
    J Alzheimers Dis; 2021 Dec; 79(1):25-30. PubMed ID: 33216037
    [Abstract] [Full Text] [Related]

  • 7. Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation.
    Ghezzi L, Carandini T, Arighi A, Fenoglio C, Arcaro M, De Riz M, Pietroboni AM, Fumagalli GG, Basilico P, Calvi A, Scarioni M, Colombi A, Serpente M, Marotta G, Benti R, Scarpini E, Galimberti D.
    Neurology; 2017 Dec 12; 89(24):2503-2505. PubMed ID: 29142083
    [No Abstract] [Full Text] [Related]

  • 8. Nasu-Hakola Disease.
    Samanci B, Ulukan Ç, Gündüz T, Kürtüncü M, Eraksoy M.
    Neurol India; 2018 Dec 12; 66(1):263. PubMed ID: 29323005
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
    Satoh J.
    Brain Nerve; 2016 May 12; 68(5):543-50. PubMed ID: 27156507
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adult onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) and Nasu-Hakola disease: lesion staging and dynamic changes of axons and microglial subsets.
    Oyanagi K, Kinoshita M, Suzuki-Kouyama E, Inoue T, Nakahara A, Tokiwai M, Arai N, Satoh JI, Aoki N, Jinnai K, Yazawa I, Arai K, Ishihara K, Kawamura M, Ishizawa K, Hasegawa K, Yagisita S, Amano N, Yoshida K, Terada S, Yoshida M, Akiyama H, Mitsuyama Y, Ikeda SI.
    Brain Pathol; 2017 Nov 12; 27(6):748-769. PubMed ID: 27608278
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.
    Satoh J, Kino Y, Motohashi N, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K.
    Neuropathology; 2015 Dec 12; 35(6):529-37. PubMed ID: 26087043
    [Abstract] [Full Text] [Related]

  • 16. Nasu-Hakola disease (PLOSL): report of five cases and review of the literature.
    Madry H, Prudlo J, Grgic A, Freyschmidt J.
    Clin Orthop Relat Res; 2007 Jan 12; 454():262-9. PubMed ID: 16906106
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gray matter lesions in Nasu-Hakola disease: a report on three autopsy cases.
    Aoki N, Tsuchiya K, Togo T, Kobayashi Z, Uchikado H, Katsuse O, Suzuki K, Fujishiro H, Arai T, Iseki E, Anno M, Kosaka K, Akiyama H, Hirayasu Y.
    Neuropathology; 2011 Apr 12; 31(2):135-43. PubMed ID: 20880319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease.
    Galimberti D, Fenoglio C, Ghezzi L, Serpente M, Arcaro M, D'Anca M, De Riz M, Arighi A, Fumagalli GG, Pietroboni AM, Piccio L, Scarpini E.
    Cytokine; 2019 Apr 12; 116():115-119. PubMed ID: 30690291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.